Direxion Daily S&P Biotech Bull 3X ETF (NY:LABU)
Price and Volume
Detailed Quote| Volume | 158,635 |
| Open | 224.56 |
| Bid (Size) | 209.25 (600) |
| Ask (Size) | 209.91 (200) |
| Prev. Close | 222.94 |
| Today's Range | 205.00 - 224.56 |
| 52wk Range | 108.72 - 341.93 |
| Shares Outstanding | 102,744 |
| Dividend Yield | 1.74% |
Top News
More News
Performance
52-Week Range
38.7% below 52-week high
209.50
108.7252W Low
341.9352W High
1 Week
14.9% below 1-week high
203.301W Low
246.221W High
Direxion Daily S&P Biotech Bull 3X ETF (LABU) traded between $108.72 and $341.93 over the past 52 weeks and last traded at $209.50, 38.7% below its 52-week high. Over the past week it ranged between $203.30 and $246.22.
Past 12 Months
-13.8%
-16.3%
-17.8%
+6.5%
+33.0%
+78.2%
1W
-$33.59
1M
-$40.90
3M
-$45.30
6M
+$12.82
YTD
+$52.00
1Y
+$91.91
LABU was +78.2% over the past year, +6.5% over six months, +33.0% year to date, -13.8% in the last week.
12 Months vs Market
LABU
+78.2%
DIA
+13.1%
SPY
+16.1%
QQQ
+20.0%
IWM
+9.7%
Over the past 12 months LABU returned +78.2% versus DIA (Dow) +13.1%, SPY (S&P 500) +16.1%, QQQ (Nasdaq 100) +20.0% and IWM (Russell 2000) +9.7%.
Volume & Liquidity
0.40× 3-mo avg
Today 158,635
3-mo avg 394.9K
1W
418.4K
1M
443.8K
3M
394.9K
6M
483.3K
YTD
546.3K
1Y
599.2K
LABU most recently traded 158,635 shares against a 3-month average daily volume of 394.9K.
More News
Read More
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗
November 27, 2025
Via Stocktwits
Topics
ETFs
Sector Rotation ↗
January 08, 2022
Via Talk Markets
Can These 5 Assets Skyrocket Your Portfolio? ↗
September 22, 2024
Via Talk Markets
Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win ↗
June 06, 2024
Via Talk Markets
The 3 Best Leveraged ETFs for April 2024 ↗
April 02, 2024
Via InvestorPlace
Topics
ETFs
5 Best-Performing Leveraged ETFs Of February ↗
March 02, 2024
Via Talk Markets
Stocks To Watch This Week - Sunday, Feb. 11 ↗
February 11, 2024
Via Talk Markets
Topics
ETFs
Want Diversified Upside in Biotechnology? Check out LABU
March 22, 2023
Via MarketBeat
The Week Ahead Commentary - Saturday, Feb. 4 ↗
February 05, 2023
Via Talk Markets
Via Talk Markets
3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty ↗
February 22, 2022
Via InvestorPlace
3 Biotech Stocks to Buy That Are Under Severe Pressure ↗
January 13, 2022
Via InvestorPlace
5 Best Leveraged ETFs of Last Week ↗
December 28, 2021
Via Talk Markets
5 Best-Performing Leveraged ETFs of August ↗
September 01, 2021
Via Talk Markets
The Week In Charts: Figure This Out And You’ll Own The World ↗
August 07, 2021
Via Talk Markets
Via Talk Markets
A Biotech ETF For Aggressive, Risk-Tolerant Investors ↗
June 08, 2021
Via Talk Markets
Topics
Stocks
Frequently Asked Questions
Is Direxion Daily S&P Biotech Bull 3X ETF publicly traded?
Yes, Direxion Daily S&P Biotech Bull 3X ETF is publicly traded.
What exchange does Direxion Daily S&P Biotech Bull 3X ETF trade on?
Direxion Daily S&P Biotech Bull 3X ETF trades on the New York Stock Exchange
What is the ticker symbol for Direxion Daily S&P Biotech Bull 3X ETF?
The ticker symbol for Direxion Daily S&P Biotech Bull 3X ETF is LABU on the New York Stock Exchange
What is the current price of Direxion Daily S&P Biotech Bull 3X ETF?
The current price of Direxion Daily S&P Biotech Bull 3X ETF is 209.50
When was Direxion Daily S&P Biotech Bull 3X ETF last traded?
The last trade of Direxion Daily S&P Biotech Bull 3X ETF was at 10/16/26 10:51 AM ET
What is the market capitalization of Direxion Daily S&P Biotech Bull 3X ETF?
The market capitalization of Direxion Daily S&P Biotech Bull 3X ETF is 21.52M
How many shares of Direxion Daily S&P Biotech Bull 3X ETF are outstanding?
Direxion Daily S&P Biotech Bull 3X ETF has 22M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>